Photon-counting detector CT with iodine quantification: improved distinction between bland and neoplastic portal vein thrombosis

Category	Detail
Condition	Portal vein thrombosis (PVT) in hepatocellular carcinoma (HCC) and other malignancies
Key Mechanisms	Differentiation of bland versus neoplastic PVT using iodine density (ID) measurements from photon-counting detector CT (PCD-CT)
Target Population	Patients with suspected PVT, including those with HCC and other malignancies
Care Setting	Radiology departments utilizing CT imaging, particularly PCD-CT

Neoplastic PVT occurs in up to 40% of HCC patients and significantly impacts prognosis and treatment decisions.
Distinguishing bland from neoplastic PVT is challenging; biopsy is risky, making imaging the primary diagnostic tool.
PCD-CT provides spectral iodine quantification with every scan without additional radiation, potentially improving PVT differentiation.

Use cross-sectional imaging as the primary diagnostic approach to differentiate bland and neoplastic PVT.
MRI offers highest accuracy but may be limited by contraindications or ascites; CT remains crucial.
Incorporate iodine density measurements from PCD-CT to enhance differentiation between PVT subtypes.

Treatment decisions should consider the presence and type of PVT due to prognostic implications.
Avoid direct biopsy of PVT due to risks including tumor seeding and bleeding complications.

Use integrated evaluation including contrast-enhanced CT, follow-up MRI and ultrasound, clinical and laboratory data, and interdisciplinary tumor board discussions for PVT classification and monitoring.

Biopsy of PVT carries risks such as tumor seeding and bleeding, especially in patients with liver cirrhosis.
Radiation exposure concerns are mitigated by PCD-CT as it provides spectral data without additional dose.

Patients with suspected portal vein thrombosis in the context of HCC or other malignancies undergoing PCD-CT imaging.

Iodine quantification via PCD-CT can guide differentiation of PVT subtype, influencing prognosis and treatment strategy without invasive biopsy.

Employ PCD-CT with iodine quantification routinely for patients with suspected PVT to improve diagnostic accuracy.
Select the optimal contrast-enhanced phase (arterial vs portal venous) for iodine density measurement based on emerging evidence to standardize protocols.
Integrate imaging findings with clinical, laboratory, and follow-up data for comprehensive PVT assessment.
Classify PVT extent using standardized anatomical classifications (e.g., Liver Cancer Study Group of Japan) for consistent reporting.

Clinical Scorecard: Enhanced Differentiation of Bland and Neoplastic Portal Vein Thrombosis Using Photon-Counting Detector CT with Iodine Quantification